Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group

Authors :: Elena del Alcázar
Anna López-Ferrer
Álvaro Martínez-Doménech
Marc Julià
Ricardo Ruiz-Villaverde
Lourdes Rodríguez Fernández-Freire
Jaime Notario
Mar Llamas-Velasco
Marta Ferran
José Manuel Carrascosa
Source :: JOURNAL OF DERMATOLOGICAL TREATMENT, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname
Publication Year :: 2022
Publisher :: Informa UK Limited, 2022.

Tools